PLSE · Insider Trading
Pulse Biosciences, Inc Common Stock (DE)
Every open-market purchase and sale reported by PLSE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Liane Rae Teplitsky | Chief Operating Officer | Buy | +2,025 | +$99.97K |
| 2026-08-28 | Jon Skinner | Chief Financial Officer | A | +300,000 deriv. | — |
| 2026-08-28 | Liane Rae Teplitsky | Chief Operating Officer | Buy | +2,070 | +$99.97K |
| 2026-08-28 | Liane Rae Teplitsky | Chief Operating Officer | A | +900,000 deriv. | — |
| 2026-06-15 | Manmeet Singh Soni | Director | A | +30,000 deriv. | — |
| 2026-06-15 | Mahkam Zanganeh | Director | A | +44,504 deriv. | — |
| 2026-06-15 | Robert W Duggan | Director | A | +42,495 deriv. | — |
| 2026-06-15 | Maria Sainz | Director | A | +33,793 deriv. | — |
| 2026-06-15 | Broek Richard van den | Director | A | +38,423 deriv. | — |
| 2026-05-15 | Robert W Duggan | Director | Buy | +660,233 | +$13.00M |
| 2026-05-11 | Paul A Laviolette | Chief Executive Officer | Buy | +15,000 | +$295.35K |
| 2026-05-11 | Robert W Duggan | Director | Buy | +660,233 | +$13.00M |
| 2026-05-11 | Paul A Laviolette | Chief Executive Officer | Buy | +15,000 | +$295.35K |
| 2026-04-03 | Darrin Uecker | Chief Technology Officer | A | +100,000 deriv. | — |
| 2026-02-23 | Kevin Patrick Danahy | Chief Commercial Officer | MIXED | — | −$110.55K |
| 2026-02-17 | Kevin Patrick Danahy | Chief Commercial Officer | MIXED | — | −$1.32M |
| 2026-02-11 | Kevin Patrick Danahy | Chief Commercial Officer | MIXED | — | −$1.31M |
| 2026-02-06 | Maria Sainz | Director | A | +53,104 deriv. | — |
| 2025-10-07 | Kevin Patrick Danahy | Chief Commercial Officer | MIXED | — | −$78.20K |
| 2025-09-22 | Kevin Patrick Danahy | Chief Commercial Officer | MIXED | — | −$345.98K |
| 2025-09-18 | Darrin Uecker | Chief Technology Officer | MIXED | +161,534 | +$94.94K |
| 2025-09-15 | Darrin Uecker | Chief Technology Officer | MIXED | — | −$821.75K |
| 2025-09-12 | Robert W Duggan | Director | Buy | +192,599 | +$2.79M |
| 2025-08-19 | Broek Richard van den | Director | A | +30,000 deriv. | — |
| 2025-08-19 | Manmeet Singh Soni | Director | A | +30,000 deriv. | — |
| 2025-08-19 | Robert W Duggan | Director | A | +50,792 deriv. | — |
| 2025-08-19 | Mahkam Zanganeh | Director | A | +54,134 deriv. | — |
| 2025-07-16 | Steven Weber | Principal Accounting Officer | A | +55,000 deriv. | — |
| 2025-06-16 | Darrin Uecker | Chief Technology Officer | Sell | −30,000 | −$485.70K |
| 2025-02-11 | Mahkam Zanganeh | Director | X | +60,242 | +$662.66K |
| 2025-01-13 | Paul A Laviolette | Chief Executive Officer | A | +1,500,000 deriv. | — |
| 2024-12-20 | Burke Thomas Barrett | — | Sell | −50,000 | −$871.00K |
| 2024-12-18 | Robert W Duggan | Director | X | +5,306,156 | +$58.37M |
| 2024-12-17 | Robert W Duggan | Director | Buy | +45,404 | +$777.77K |
| 2024-12-17 | Robert W Duggan | Director | Buy | +55,256 | +$949.30K |
| 2024-12-13 | Robert W Duggan | Director | Buy | +56,054 | +$972.34K |
| 2024-09-30 | Mitchell E. Levinson | Chief Strategy Officer | X | +5,206 | +$57.27K |
| 2024-08-13 | Mahkam Zanganeh | Director | A | +200,000 deriv. | — |
| 2024-08-13 | Paul A Laviolette | Director | A | +250,000 deriv. | — |
| 2024-08-13 | Manmeet Singh Soni | Director | A | +200,000 deriv. | — |
| 2024-07-22 | Burke Thomas Barrett | President and CEO | X | +1,086 | +$11.95K |
| 2024-07-09 | Kevin Patrick Danahy | Chief Commercial Officer | X | +650 | — |
| 2024-07-09 | Mahkam Zanganeh | Director | X | +60,242 | — |
| 2024-07-09 | Robert W Duggan | Director | X | +5,306,156 | — |
| 2024-07-08 | Burke Thomas Barrett | President and CEO | X | +1,086 | — |
| 2024-07-08 | Mitchell E. Levinson | Chief Strategy Officer | X | +5,207 | — |
| 2024-06-24 | Mahkam Zanganeh | Director | A | +28,247 deriv. | — |
| 2024-06-24 | Broek Richard van den | Director | A | +31,649 deriv. | — |
| 2024-06-24 | Burke Thomas Barrett | President and CEO | A | +1,400,000 deriv. | — |
| 2024-06-24 | Manmeet Singh Soni | Director | A | +20,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Robert W Duggan | Director | 48,820,236 | $2.32B |
| Mahkam Zanganeh | Director | 802,348 | $38.15M |
| Darrin Uecker | Chief Technology Officer | 284,406 | $13.52M |
| Burke Thomas Barrett | President and CEO | 63,172 | $3.00M |
| Kevin Patrick Danahy | Chief Commercial Officer | 48,298 | $2.30M |
| Paul A Laviolette | Chief Executive Officer | 15,000 | $713.25K |
| Liane Rae Teplitsky | Chief Operating Officer | 3,094 | $147.12K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PLSE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.